s6y

3 AVANIR PHARMACEUTICALS: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001186120-05-000017

Documents

  1. PRIMARY DOCUMENT 3
  2. PRIMARY DOCUMENT 3

On sec.gov